Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma

Haematologica. 2020 Jul;105(7):e337-e339. doi: 10.3324/haematol.2019.229856. Epub 2019 Nov 7.

Seiichiro Katagiri¹, Hideki Makishima², Kenko Azuma^{3

4}, Yasuhito Nannya², Yuu Saitoh¹, Seiichiro Yoshizawa¹, Daigo Akahane¹, Hiroaki Fujimoto¹, Yoshikazu Ito¹, Ravi Velaga², Tomohiro Umezu^{1

5}, Junko H Ohyashiki⁵, Seishi Ogawa^{2

6

7}, Kazuma Ohyashiki^{1

5}

¹ Department of Hematology, Tokyo Medical University, Tokyo, Japan.
² Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
³ Department of Molecular Oncology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
⁴ Current address: Tokyo Women's Medical University Institute for Integrated Medical Sciences (TIIMS), Tokyo, Japan.
⁵ Department of Advanced Cellular Therapy, Tokyo Medical University, Tokyo, Japan.
⁶ Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
⁷ Department of Medicine, Centre for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.

No abstract available

Publication types